CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase III, Single-blind, Randomized Study to Evaluate the Immunogenicity and Safety of Fluarix® (GSK Biologicals') Compared With Fluzone® (Aventis Pasteur/Sanofi) Administered Intramuscularly in Children (6 Months and Older)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00383123
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:54.128566+00:00
Published At: 2008-12-04T00:00:00+00:00
Record Updated At: 2018-06-08
Results Posted At: 2008-12-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Influenza"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-06-08"
protocolSection.identificationModule.nctId: "NCT00383123"
protocolSection.identificationModule.officialTitle: "A Phase III, Single-blind, Randomized Study to Evaluate the Immunogenicity and Safety of Fluarix\u00ae (GSK Biologicals\u0027) Compared With Fluzone\u00ae (Aventis Pasteur/Sanofi) Administered Intramuscularly in Children (6 Months and Older)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2008-12-04"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.